BeOne Medicines AG (6160.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
BeOne Medicines AG
Address
Aeschengraben 27
Basel, BL 4051
Switzerland
Phone
41 61 685 19 00
Website
Sector
Healthcare
Industry
Biotechnology
Employees
12000
First IPO Date
August 08, 2018
Key Executives
| Name | Title | Pay | Year Born |
| John V. Oyler | Co-Founder, Executive Chairman & Chief Executive Officer | 23.08M | 1968 |
| Chan Lee | General Counsel, Senior VP & Corporate Secretary | 9.85M | 1968 |
| Aaron Rosenberg | Chief Financial Officer | 9.94M | 1977 |
| Wang Lai | President and Global Head of Research & Development | 10.35M | 1977 |
| Xiaodong Wang | Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | 33.32M | 1963 |
| Titus Ball | Vice President & Chief Accounting Officer | 0 | 1974 |
| Eleanor Duff | Senior Vice President & Head of Corporate Communications | 0 | N/A |
| Liza Heapes | Head of Investor Relations | 0 | N/A |
| Graham Hardiman | Global Head of Human Resources | 0 | N/A |
| Marcello Damiani | Chief Technology Officer | 0 | 1970 |
| Mark Lanasa | Senior Vice President & Chief Medical Officer for Solid Tumors | 0 | N/A |
AD
Description
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
AD
